Merck & Co. has been playing fast and loose with the truth for years relating to its testing and marketing of Vioxx. Finally, in an admission that undermines its core defense in Vioxx-related lawsuits, Merck has finally decided to tell the truth. Merck now says it erred when it reported in early 2005 that a crucial statistical test showed that Vioxx caused heart problems only after 18 months of...
One of today's top Reuters headlines talks of a new barrage of Vioxx litigation over this defective drug that has been proven to cause strokes and heart attacks. Though a case in Texas was recently dropped by a plaintiff just two weeks before trial, several others move forward and will soon go to trial, including one in an Alabama state court. Drug manufacturer Merck & Co. is facing more than...
The 2004 approval of the antibiotic Ketek, is a "mistake," according to FDA safety official Dr. David Graham. Graham suggested immediate withdrawal of the controversial antibiotic, citing its toxicity and lack of adequate safety research. Over five million prescriptions have been written for Ketek, which has been linked to reports of liver damage, blurred vision, loss of consciousness, and death.